New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
Go back to New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 72.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.53 | 52 Week High | $39.41 | |||
| Open | $72.53 | 52 Week Low | $25.98 | |||
| Day High | $72.53 | P/E | 102.15 | |||
| Day Low | $72.53 | EPS | $0.71 | |||
| Volume | 5 | |||||
